Header Logo

Connection

Douglas Corley to Incidence

Back to Details
This is a "connection" page, showing publications Douglas Corley has written about Incidence.
Douglas Corley
Connection Strength
1.724
Incidence
  1. Rising Early-onset Colorectal Cancer Incidence Is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System. Gastroenterology. 2022 01; 162(1):325-327.e3.
    View in: PubMed
    Score: 0.142
  2. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol. 2021 05 01; 116(5):949-957.
    View in: PubMed
    Score: 0.139
  3. When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. Gastroenterology. 2018 10; 155(4):947-949.
    View in: PubMed
    Score: 0.115
  4. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018 03; 67(3):418-529.
    View in: PubMed
    Score: 0.103
  5. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2015 Feb; 29(1):29-39.
    View in: PubMed
    Score: 0.089
  6. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel. J Natl Cancer Inst. 2011 Jul 06; 103(13):994-5.
    View in: PubMed
    Score: 0.070
  7. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
    View in: PubMed
    Score: 0.064
  8. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
    View in: PubMed
    Score: 0.058
  9. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
    View in: PubMed
    Score: 0.058
  10. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med. 2008 Jun; 121(6):525-31.
    View in: PubMed
    Score: 0.057
  11. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway? Gastrointest Endosc. 2008 Mar; 67(3):399-401.
    View in: PubMed
    Score: 0.056
  12. Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut. 2007 Nov; 56(11):1493-4.
    View in: PubMed
    Score: 0.054
  13. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.052
  14. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
    View in: PubMed
    Score: 0.044
  15. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004 Apr; 99(4):582-8.
    View in: PubMed
    Score: 0.042
  16. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002 Nov 15; 95(10):2096-102.
    View in: PubMed
    Score: 0.039
  17. Association between Improved Colorectal Screening and Racial Disparities. N Engl J Med. 2022 02 24; 386(8):796-798.
    View in: PubMed
    Score: 0.037
  18. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001 Dec; 30(6):1415-25.
    View in: PubMed
    Score: 0.036
  19. Standardized Reporting and Management of Suspicious Findings on Chest CT Imaging Is Associated With Improved Lung Cancer Diagnosis in an Observational Study. Chest. 2020 11; 158(5):2211-2220.
    View in: PubMed
    Score: 0.033
  20. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.032
  21. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. Cancer Causes Control. 2020 Jan; 31(1):85-93.
    View in: PubMed
    Score: 0.031
  22. Incidence rates of cardiovascular outcomes in a community-based population of cancer patients. Cancer Med. 2019 12; 8(18):7913-7923.
    View in: PubMed
    Score: 0.031
  23. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019 Oct 02; 367:l5515.
    View in: PubMed
    Score: 0.031
  24. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
    View in: PubMed
    Score: 0.031
  25. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 11; 155(5):1383-1391.e5.
    View in: PubMed
    Score: 0.029
  26. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164.
    View in: PubMed
    Score: 0.027
  27. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
    View in: PubMed
    Score: 0.025
  28. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
    View in: PubMed
    Score: 0.024
  29. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
    View in: PubMed
    Score: 0.023
  30. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015 Jun; 148(7):1353-61.e3.
    View in: PubMed
    Score: 0.023
  31. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
    View in: PubMed
    Score: 0.022
  32. Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014 Sep; 25(9):2313-8.
    View in: PubMed
    Score: 0.022
  33. Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. J Gastroenterol. 2014 Jun; 49(6):992-1000.
    View in: PubMed
    Score: 0.021
  34. Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries? Am J Surg. 2012 Apr; 203(4):480-7.
    View in: PubMed
    Score: 0.018
  35. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011 Aug; 60(8):1029-37.
    View in: PubMed
    Score: 0.017
  36. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010 Sep 08; 102(17):1344-53.
    View in: PubMed
    Score: 0.017
  37. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1366-72; quiz 1301.
    View in: PubMed
    Score: 0.013

© 2025 Kaiser Permanente

Your Privacy Choices